newsfilter
← Latest News
GlobeNewswire·

Nasdaq Grants BiondVax Extension to Regain Compliance with Listing Rules

JERUSALEM, Aug. 01, 2023 (GLOBE NEWSWIRE) -- via IBN -- BiondVax Pharmaceuticals Ltd. (NASDAQ:BVXV), a biotechnology company focused on developing, manufacturing, and commercializing innovative immunotherapeutic